|
|
Other links at Articles > Neurology and Neurosurgery |
| 4. |
Infantile Spasm Drug Gets FDA Orphan Status
|
|
|
Catalyst Pharmaceutical Partners Inc said its experimental treatment for infantile spasms received orphan drug designation from the U.S. Food and Drug Administration. Reuters Health Information
|
|
|